OCT 03, 2020 3:30 PM PDT

Cannabis Compound Prevents Colon Cancer in Mice

WRITTEN BY: Annie Lennon

Second only to skin cancer, colon cancer is the most common cancer diagnosed in both men and women in the US. Now, researchers from the University of South Carolina have found that tetrahydrocannabinol (THC), the psychoactive compound in cannabis, can prevent colon cancer linked to ulcerative colitis in mice. 

For the study, the researchers split mice with colitis-associated colon cancer into two groups. One was treated with THC and the other: a placebo. By the end of the study, they found that those treated with THC had no tumors, unlike those who received the placebo. Those in the THC group also had less inflammation in their colons, a symptom of inflammatory bowel disease. 

The researchers say that THC has this effect as it binds to cannabinoid receptor type 2 (CB2), which is expressed in immune cells throughout the gastrointestinal system. This binding triggers an anti-inflammatory process, which makes intestinal cells secrete anti-inflammatory molecules instead of pro-inflammatory ones. These cells then help recruit regulatory T cells, a type of cell that can resolve inflammation and protect against cancer. 

“The fact that we were able to show that treatment with THC prevents inflammation in the colon and at the same time inhibits the development of colon cancer supports the notion that inflammation and colon cancer are closely linked,” says Dr. Prakash Nagarkatti, a senior author of the study. 

The researchers say that their findings suggest that people who are at higher risk of developing colon cancer may benefit from using THC or other anti-inflammatory agents. They warn, however, that their study indicates a preventative rather than a curative effect, and that it is too early to recommend cannabis to prevent colon cancer. As such, future efforts will likely focus on developing non-psychoactive compounds that can target CB2 receptors in the immune system similarly to THC.

 

Sources: Medical News TodayiScience

 

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
APR 20, 2021
Health & Medicine
Cannabis Users Tend to Exercise More
APR 20, 2021
Cannabis Users Tend to Exercise More
Two recent studies have shown that far from performing less exercise, people who use marijuana are actually more active. ...
MAY 01, 2021
Cannabis Sciences
Early Use of Cannabis Linked to Heart Disease
MAY 01, 2021
Early Use of Cannabis Linked to Heart Disease
While the dangers of cigarette smoking to cardiovascular health are widely known, those for cannabis have been less rese ...
MAY 04, 2021
Health & Medicine
Micro-dosing Inhaler Breakthrough for Medical Cannabis
MAY 04, 2021
Micro-dosing Inhaler Breakthrough for Medical Cannabis
In a leap that will eliminate the risks of vaping or smoking, Canada has just approved an Israeli-made inhaler that is a ...
MAY 12, 2021
Cannabis Sciences
Cannabis Users with Heart Disorders More Likely to Die in Hospital
MAY 12, 2021
Cannabis Users with Heart Disorders More Likely to Die in Hospital
Researchers have found that hospitalized cannabis users with arrhythmia, a heart rhythm disorder, are 4.5 times more lik ...
JUL 05, 2021
Cannabis Sciences
Long Term CBD Use Linked to Less Pain, Anxiety and Depression
JUL 05, 2021
Long Term CBD Use Linked to Less Pain, Anxiety and Depression
Researchers from Canada have found that long-term use of cannabidiol (CBD) is linked to improved symptoms of pain, anxie ...
AUG 11, 2021
Health & Medicine
Cannabis Users Are Normal Hardworking Members of the Community Too
AUG 11, 2021
Cannabis Users Are Normal Hardworking Members of the Community Too
  Who is the typical cannabis user? There are many stereotypes and misconception about weed use, most of them not f ...
Loading Comments...